Lung Damage From Vaping in Mice The e-cigarette industry adamantly promotes vaping as a safe alternative to smoking regular cigarettes. Not true, according to a study published in the American Journal of Physiology, Lung Cellular and Molecular Physiology. The study used mice to compare the relative damage to lungs when exposed to regular cigarettes, e-juice… Read More
March 23, 2018: The Federal Drug Administration (FDA) released a new warning regarding Benzocaine (also known as Orajel, Baby Orajel, Anbesol, Hurricane and other brands) which are marketed as a pain reliever in teething babies: [Benzocaine and Orajel products] carry serious risks and provide little to no benefits for treating oral pain, including sore gums in… Read More
R.J. Reynolds Vapor Company initiated a voluntary recall of Vuse Vibe power units, recalling the battery portion of all Vuse Vibe vape devices. The recall followed consumer complaints of power devices overheating which can create a risk for fire or injury. The recall covers all 2.6 million Vuse Vibe devices sold. Recall Instructions: Stop using your Vuse Vibe Unscrew… Read More
ProPublica studied five different specialties to compare the rates by which doctors who receive money from big pharma prescribe typically more expensive brand name medication, versus doctors who haven’t taken money from pharma. The analysis found that doctors who receive $5,000 or more from pharmaceutical companies in a given year all prescribe more brand name… Read More
The Federal Drug Administration (FDA) has labeled Pelvic Organ Prolapse (POP) devices as “high risk”, after thousands of injuries had been reported. The FDA noted more than 4,000 reports of adverse events or complications associated with transvaginal surgical mesh for POP or Stress Urinary Incontinence (SUI) repair from 2005 to 2010. The FDA previously classified POP surgical… Read More
An article published in November in BioMed Central discovered serious differences between studies funded by pharmaceutical companies selling testosterone therapy drugs, and those that were independent of pharmaceutical companies pushing the drugs. Combined with the FDA warning1 in January on the risks of testosterone therapy, including heart attacks and strokes, this paints a troubling picture… Read More
On January 31, 2014 the FDA published a warning on the risks of testosterone therapy1. This warning prompted news organizations to cover stories about these new risks, and now prominent consumer productions agencies are calling for changes to the warning labels of testosterone therapy products2. Public Citizen is a consumer advocacy organization with more than… Read More
Earlier this year, a group of private companies and institutions released a new mobile application in collaboration with the Food and Drug Administration Center for Devices and Radiologic Health. It is called MedWatcher, and is a mobile app for use on tablets and smartphones to make reporting negative effects of drugs, medical devices, and vaccines… Read More
